Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.
19.09.2021
Find out why animals are not always ideal when studying potential treatments for diseases like Alzheimer's.
19.09.2021 Published by Massive Science
bit.bio offering a reliable and consistent source of human cells
This piece covers what's different about our cell coding approach.
Anthony Browne MP officially opens Cambridge headquarters
MP Anthony Browne visits bit.bio's labs and offices to officially open facilities.
The USA is seeing huge growth in synbio. UK mustn't miss out.
America is seeing huge growth in Synthetic Biology – the UK must ensure it doesn’t miss out.
When human stem cells take the shortcut
bit.bio's Founder and CEO Mark Kotter talks to Kurier about reprogramming cells for therapies.
£200m+ invested in Babraham Campus companies, what lies ahead?
Read about the Babraham Investor Conference 2021 focusing on early-stage and scale-up life science and med-tech companies.
How the body's building blocks will revolutionise medicine
This piece focuses on the promise of stem cells for cell therapies.
Davide Danovi, Head of Cellular Phenotyping talks at Sci Foo
Sci Foo Camp is run by Digital Science, Google, Nature Publishing Group and O’Reilly Media.
Former CEO and founder Mark Kotter on Spectator TV about cultured meat
Cindy Yu talks to Mark Kotter about cultured meat and its possible impact on sustainability.
Loading form…